Clinical outcome and immune reconstitution following alemtuzumab T cell depleted nonmyeloablative allogeneic immunotherapy from HLA matched siblings.
Conference Paper
Full Text
Duke Authors
Cited Authors
- Rizzieri, DA; Koh, LP; Long, GD; Lagoo, AS; Gasparatto, C; Vredenburgh, JJ; Buckley, PJ; Gong, G; Loftis, J; Rowe, K; Rooney, B; Niedzweicki, D; Waters-Pick, B; Eren, P; Vujevich, D; Catlin, C; Folz, RJ; Sullivan, K; Horwitz, ME; Morris, A; Chao, NJ
Published Date
- November 16, 2003
Published In
Volume / Issue
- 102 / 11
Start / End Page
- 238A - 239A
Published By
Pages
- 2
International Standard Serial Number (ISSN)
- 0006-4971
Conference Name
- 45th Annual Meeting of the American-Society-of-Hematology
Conference Location
- SAN DIEGO, CALIFORNIA
Conference Start Date
- December 6, 2003
Conference End Date
- December 9, 2003